Paclitaxel plus garboplatin in advanced non-small-cell lung cancer

ONCOLOGY

Volumn 13, Issue 9 SUPPL. 4, 1999, Pages 30-34

  Rosell, Rafael ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002118193     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Estève J, Kricker A, Ferlay J, et al: Facts and figures of cancer in the European community. International Agency for Research on Cancer, Lyon, France, 1993.
2. Bonfill X, Moreno C, Prada G, et al: Lung cancer mortality among males of Catalonia and Spain compared with other European countries between 1975-1977 and 1987-1989. Int J Cancer 65:751-754,1996.
3. Moreno V, Sánchez V, Galceran J, et al: Riesgo de enfermar y morir por cancer en Cataluna. Med Clìn (Bare) 110:86-93, 1998.
4. Non-Small-Cell Lung Cancer Collaborative Group: Chemotherapy in non-small-cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br Med J 311:899-909, 1995.
5. Bonomi P, Kim K, Chang A, et al: Phase III trial comparing etoposide, cisplatin versus Taxpl, cisplatin, G-CSF versus Taxol, cisplatin in advanced non-small-cell lung cancer. An Eastern Cooperative Oncology Group trial (abstract 1145). Proc Am Soc Clin Oncol 15:382, 1996.